作者: L A Price , I E Smith
DOI: 10.1136/BMJ.308.6936.1103A
关键词: Oncology 、 Advanced breast 、 Combination chemotherapy 、 Cancer 、 Palliative chemotherapy 、 Non small cell 、 Chemotherapy 、 Internal medicine 、 Medicine 、 General Medicine
摘要: EDITOR, - I E Smith's editorial on palliative chemotherapy for advanced non-small cell lung cancer contains a worrying error of fact.1 The statement that an average improvement in survival around three months after is more than has been shown breast not …